810130C
16:0-06:0 NBD PC
Manufacturer: Sigma Aldrich
CAS Number: 91992-01-7
Synonym(S): 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810130C-1-MG | In Stock | ₹ 21,345.75 |
| 5 MG | 810130C-5-MG | In Stock | ₹ 31,601.25 |
810130C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 21,345.75
GST (18%): ₹ 3,842.235
Total Price: ₹ 25,187.985
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810130C-1mg)pkg of 5 × 1 mL (810130C-5mg)
manufacturer/tradename
Avanti Polar Lipids 810130C
concentration
1 mg/mL (810130C-1mg)1 mg/mL (810130C-5mg)
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Avanti Polar Lipids 16:0-06:0 NBD PC, Powder | 91992-01-7 | MFCD00082438 | 5 mg | Avanti Polar Lipids | ₹ 31,029.19 | |
 | 16:0-06:0 NBD PC | Sigma Aldrich | ₹ 23,587.68 - ₹ 34,715.78 | |
 | 91992-01-7 | 16:0-06:0 NBD PC | A2B Chem | -- |
Related Products
Description
- General description: Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism.[1] 16:0-06:0 NBD PC is a fluorescent lipid.[2]
- Application: 16:0-06:0 NBD PC I suitable for use:in the preparation of fluid phase fluorescent bilayers[2]to prepare liposomes/small unilamellar vesicles (SUVs)[3]as substrate in in vitro enzyme assay of lipoteichoic acid (LTA) synthase enzyme (LtaS) to determine the enzyme specificity[4]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810130C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810130C-1mg)pkg of 5 × 1 mL (810130C-5mg)
manufacturer/tradename: Avanti Polar Lipids 810130C
concentration: 1 mg/mL (810130C-1mg)1 mg/mL (810130C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810130C-1mg)pkg of 5 × 1 mL (810130C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810130C
concentration:
1 mg/mL (810130C-1mg)1 mg/mL (810130C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810130P-1mg)pkg of 5 × 1 mg (810130P-5mg)
manufacturer/tradename: Avanti Polar Lipids 810130P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810130P-1mg)pkg of 5 × 1 mg (810130P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810130P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810131C-1mg)pkg of 5 × 1 mL (810131C-5mg)
manufacturer/tradename: Avanti Polar Lipids 810131C
concentration: 1 mg/mL (810131C-1mg)1 mg/mL (810131C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810131C-1mg)pkg of 5 × 1 mL (810131C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810131C
concentration:
1 mg/mL (810131C-1mg)1 mg/mL (810131C-5mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810131P-1mg)pkg of 5 × 1 mg (810131P-5mg)pkg of 5 × 2 mg (810131P-10mg)
manufacturer/tradename: Avanti Polar Lipids 810131P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810131P-1mg)pkg of 5 × 1 mg (810131P-5mg)pkg of 5 × 2 mg (810131P-10mg)
manufacturer/tradename:
Avanti Polar Lipids 810131P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C